IHS FormWeb
Approved Formulary
Search by name
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Show Therapeutic Classes
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Search results for:
mercaptopurine
mercaptopurine
Brand names:
Purinthol
Form
Strength
TABLET, ORAL
50 mg
Display
Antineoplastic Agents
,
Immunosuppressive Agents
Class:
100000
,
924400
High Alert Drug
:
Policy
Medication comments:
Administration of Cancer Chemotherapy
High Alert
Haz.Waste
Haz.Handle
High Alert Drug: Chemotherapeutic Agents - Oral
• Designated stored location in pharmacy.
• Drugs are transported in plastic bags labeled with sticker indicating CHEMOTHERAPY DRUG.
Per policy, these hazardous drugs have special waste requirements.
View all
Generic (Brand)
Waste Requirements
mercaptopurine (Purinthol)
If > 3% by weight of drug remains ⇒
BLACK BUCKET
Trace amounts/uncontaminated PPE ⇒
YELLOW BUCKET
USP <800> Hazardous Drug Assessment of Risk (AOR)
View all
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route
[Packaging: Manufacturer ⇒ Dispense]
Activities
mercaptopurine (Purintehol, Purixan)
PO
[Bulk ⇒ Blister UD]
50 mg tablet
Stock @ IDBH? N
NIOSH Table 1
↑
Pharmacy:
Receiving / Storage / Preparation
Exposure Risk: low
• Handling/preparation PPE Requirements:
Double CX glove and gown
• Receiving from Distributor:
Designated area/ CX gloves
• Pharmacy Storage Area:
Hazardous
• Packaging/Reconstitution Location:
Repacking area
• Compounding (Non-Sterile/Sterile) Location:
n/a
• Omnicell Load:
No
Transport
• Transport (dose is placed inside a plastic sealable bag):
Standard
Nursing:
Storage / Administration
Exposure Risk: low
• Handling/administration PPE Requirements:
via Mouth- Single pair of CX approved gloves
via Tube- double CX gloves and gown
Wash hands after handling
• Storage of Finished dose in Nursing Area/Procedural Area:
Patient Med Drawer
• Signage on Patient Door Required:
Yes
• Manipulation of Dosage Form:
Done in Pharmacy
• Special Manipulation for Administration:
n/a
Disposal / Spills
• Disposal of Drug Waste:
Full-
black bin
Trace-
yellow bin
• Disposol of Used PPE:
yellow bin
• Spill management:
n/a
Reason for exemption of USP<800> Containment Requirements:
Will comply with USP 800 recommendation for preparation
Last updated:
May. 4, 2026
Hazard.Drug Handling(USP 800)
USP<800> Hazardous Drug / Assessment of Risk
Hazardous Waste
BLACK BUCKET/YELLOW BUCKET
Chemotherapy
Black Box Warnings
Bolded (not boxed): initiation of therapy
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
UpToDate Lexidrug
• Drugs are transported in plastic bags labeled with sticker indicating CHEMOTHERAPY DRUG.
Trace amounts/uncontaminated PPE ⇒ YELLOW BUCKET
The following outlines must be followed.
[Packaging: Manufacturer ⇒ Dispense]
[Bulk ⇒ Blister UD]
NIOSH Table 1↑
Receiving / Storage / Preparation
Storage / Administration
via Tube- double CX gloves and gown
Wash hands after handling
Trace- yellow bin